Viewing Study NCT02862132


Ignite Creation Date: 2025-12-24 @ 9:46 PM
Ignite Modification Date: 2026-01-04 @ 4:41 PM
Study NCT ID: NCT02862132
Status: COMPLETED
Last Update Posted: 2022-10-25
First Post: 2016-07-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases
Sponsor: Shaare Zedek Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module